| Trevor Carl Neal, MD | |
|
100 Hospital Dr, Bennington, VT 05201-5004 | |
| (802) 447-5023 | |
| Not Available |
| Full Name | Trevor Carl Neal |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 14 Years |
| Location | 100 Hospital Dr, Bennington, Vermont |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083900229 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 042.0013806 (Vermont) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Southwestern Vermont Medical Center | Bennington, VT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southwestern Vermont Medical Center Inc | 0143138446 | 142 |
News Archive
The investigational drug AZD2171 (cediranib) may help shrink tumors and prolong survival of patients with a relatively common, aggressive type of brain cancer, according to results from a clinical trial conducted by Boston researchers.
A selection of health policy stories from Virginia, New York, California, Oregon, Michigan, Texas and Georgia.
Residents of the Italian island of Sardinia are known for their longevity. Now, a new study also shows that elderly Sardinians are less depressed and generally are in a better mental frame of mind than peers living elsewhere.
Novo Nordisk today presented phase 2 proof-of-concept data for its investigational insulin degludec, an ultra-long-acting basal insulin, which demonstrated the potential to help achieve target glycemic control when used once daily or three times weekly. These data were presented at the 70th Scientific Sessions of the American Diabetes Association.
InformedDNA, a leading provider of Genetic Benefits Management and the largest independent network of genetic specialists in the U.S., announced today that it has reached a $4.5 million funding agreement with Zaffre Investments, a wholly owned subsidiary of Blue Cross Blue Shield of Massachusetts.
› Verified 9 days ago
| Entity Name | Southwestern Vermont Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205865789 PECOS PAC ID: 0143138446 Enrollment ID: O20060929000045 |
News Archive
The investigational drug AZD2171 (cediranib) may help shrink tumors and prolong survival of patients with a relatively common, aggressive type of brain cancer, according to results from a clinical trial conducted by Boston researchers.
A selection of health policy stories from Virginia, New York, California, Oregon, Michigan, Texas and Georgia.
Residents of the Italian island of Sardinia are known for their longevity. Now, a new study also shows that elderly Sardinians are less depressed and generally are in a better mental frame of mind than peers living elsewhere.
Novo Nordisk today presented phase 2 proof-of-concept data for its investigational insulin degludec, an ultra-long-acting basal insulin, which demonstrated the potential to help achieve target glycemic control when used once daily or three times weekly. These data were presented at the 70th Scientific Sessions of the American Diabetes Association.
InformedDNA, a leading provider of Genetic Benefits Management and the largest independent network of genetic specialists in the U.S., announced today that it has reached a $4.5 million funding agreement with Zaffre Investments, a wholly owned subsidiary of Blue Cross Blue Shield of Massachusetts.
› Verified 9 days ago
| Entity Name | Southwestern Vermont Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184994162 PECOS PAC ID: 0143138446 Enrollment ID: O20120613000217 |
News Archive
The investigational drug AZD2171 (cediranib) may help shrink tumors and prolong survival of patients with a relatively common, aggressive type of brain cancer, according to results from a clinical trial conducted by Boston researchers.
A selection of health policy stories from Virginia, New York, California, Oregon, Michigan, Texas and Georgia.
Residents of the Italian island of Sardinia are known for their longevity. Now, a new study also shows that elderly Sardinians are less depressed and generally are in a better mental frame of mind than peers living elsewhere.
Novo Nordisk today presented phase 2 proof-of-concept data for its investigational insulin degludec, an ultra-long-acting basal insulin, which demonstrated the potential to help achieve target glycemic control when used once daily or three times weekly. These data were presented at the 70th Scientific Sessions of the American Diabetes Association.
InformedDNA, a leading provider of Genetic Benefits Management and the largest independent network of genetic specialists in the U.S., announced today that it has reached a $4.5 million funding agreement with Zaffre Investments, a wholly owned subsidiary of Blue Cross Blue Shield of Massachusetts.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Trevor Carl Neal, MD 100 Hospital Dr, Bennington, VT 05201-5004 Ph: (802) 447-5023 | Trevor Carl Neal, MD 100 Hospital Dr, Bennington, VT 05201-5004 Ph: (802) 447-5023 |
News Archive
The investigational drug AZD2171 (cediranib) may help shrink tumors and prolong survival of patients with a relatively common, aggressive type of brain cancer, according to results from a clinical trial conducted by Boston researchers.
A selection of health policy stories from Virginia, New York, California, Oregon, Michigan, Texas and Georgia.
Residents of the Italian island of Sardinia are known for their longevity. Now, a new study also shows that elderly Sardinians are less depressed and generally are in a better mental frame of mind than peers living elsewhere.
Novo Nordisk today presented phase 2 proof-of-concept data for its investigational insulin degludec, an ultra-long-acting basal insulin, which demonstrated the potential to help achieve target glycemic control when used once daily or three times weekly. These data were presented at the 70th Scientific Sessions of the American Diabetes Association.
InformedDNA, a leading provider of Genetic Benefits Management and the largest independent network of genetic specialists in the U.S., announced today that it has reached a $4.5 million funding agreement with Zaffre Investments, a wholly owned subsidiary of Blue Cross Blue Shield of Massachusetts.
› Verified 9 days ago
Sean Patrick Burns, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 Hospital Dr, Bennington, VT 05201 Phone: 802-442-6361 | |
Daniel E Perregaux, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 100 Hospital Dr, Bennington, VT 05201 Phone: 802-442-6361 Fax: 802-447-2469 | |
Carl W Dobson Iii, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 Hospital Dr, Bennington, VT 05201 Phone: 802-442-6361 Fax: 802-447-2469 | |
Paul L Vinsel, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 Hospital Dr, Bennington, VT 05201 Phone: 802-442-6361 Fax: 802-447-2469 | |
Adam Patrick Kaftan, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 Hospital Dr, Svmc Emergency Department, Bennington, VT 05201 Phone: 402-515-8127 | |
Jeffery A Yucht, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 100 Hospital Dr, Bennington, VT 05201 Phone: 802-442-6361 Fax: 802-447-2469 |